Electrocardiographic abnormalities during recovery from ultra-short opiate detoxification

Addiction Biology

Volumn 4, Issue 3, 1999, Pages 337-344

  Allhoff, Thomas ^a   Renzing Köhler, Katrin ^a   Kienbaum, Peter ^a   Sack, Stefan ^a   Scherbaum, Norbert ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CLONIDINE; METHADONE; NALTREXONE; OPIATE; POTASSIUM; SODIUM; TRIMIPRAMINE;

ADULT; ARTICLE; BRADYCARDIA; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; DETOXIFICATION; ELECTROCARDIOGRAPHY; ELECTROLYTE BLOOD LEVEL; FEMALE; GENERAL ANESTHESIA; HEART ATRIOVENTRICULAR NODE; HEART RATE; HUMAN; HYPOKALEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; OPIATE ADDICTION; ORAL DRUG ADMINISTRATION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; QT INTERVAL; REPOLARIZATION; RETROSPECTIVE STUDY; SINUS RHYTHM; SODIUM BLOOD LEVEL; STATISTICAL ANALYSIS;

EID: 0032868645     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556219971551     Document Type: Article

References (33)

1. Brewer C. Ultra-rapid, antagonist-precipitated opiate detoxification under general anaesthesia or sedation. Addict Biol 1997;2:291-302.
2. O'Connor PG, Kosten TR. Rapid and ultrarapid opioid detoxification techniques. JAMA 1998;279: 229-34.
3. Scherbaum N, Klein S, Kaube H, et al. Alternative strategies of opiate detoxification: evaluation of the so-called ultra-short detoxification. Pharmacopsychiatry 1998;31:205-9.
4. Strang J, Bearn J, Gossop M. Opiate detoxification under anaesthesia. Br Med J 1997;315:1249-50.
5. Byrd BF III, Collins HW, Primm RK. Risk factors for severe bradycardia during oral clonidine therapy for hypertension. Areh Intern Med 1988;148: 720-33.
6. Seoane A, Carrasco G, Cabré L, et al. Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success. Br J Psychiatry 1997;171: 340-5.
7. San L, Puig M, Bulbena A, Farre M. High risk of ultrashort noninvasive opiate detoxification. Am J Psychiatry 1995; 152:956.
8. Kienbaum P, Thürauf N, Michel MC, et al. Profound increase in epinephrinc concentration in plasma and cardiovascular stimulation after μ-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification. Anesthesiology 1998;88: 1154-61.
9. Cowan JC, Yusoff K, Moore M, et al. Importance of Lead Selection in QT Interval Measure ment. Am J Cardiol 1988;61:83-7.
10. Bazett HC. An analysis of time relations of electrocardiograms. Heart 1920;7:353-70.
11. Mendelson J, Jones RT, Fernandez I et al. Buprenorphine and naloxone interactions in opiate-dependent volunteers. Clin Pharmacol Ther 1996;60:105-14.
12. Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet 1999;353: 221-6.
13. Kors JA, de Bruyne MC, Hoes AW, et al. T-axis as an indicator of risk of cardiac events in elderly people. Lancet 1998;352:601-5.
14. De Bruyne MC, Hoes AW, Kors JA, et al. Prolonged QT interval: a tricky diagnosis? Am J Cardiol 1997;80:1300-4.
15. MvGovern B. Hypokalaemia and cardiac arrhythmias. Anesthesiology 1985;63:127-9.
16. Halperin ML, Kamel KS. Potassium. Lancet 1998; 352:135-40.
17. Tan HL, Hou CJ, Lauer MR, Sung RJ. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann Intern Med 1995;122:701-14.
18. Clementy J, Castagné D, Wicker P, Dallocchio M, Bricaud H. Study of the electrophysiologic properties of clonidine administered intravenously. J Cardiovasc Pharm 1986;8(suppl.3):S24-9.
19. McKibbin JR, Pocock WA, Barlow JB, et al. Sotalol, hypokalaemia, syncope, and torsade de pointes. Br Heart J 1984;51:157-62.
20. Burke JH, Ehlert FA, Kruse JT, et al. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol 1997;79:178-81.
21. + channel blockade and to increases in heart rate. Circulation 1995;92:3381-6.
22. Rankin AC. Non-sedating antihistamines and cardiac arrhythmia. Lancet 1997;350:1115-16.
23. Pratt CM, Ruberg S, Morganroth J, et al. Dose-response relation between terfenadine (Seldane) and the Qtc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability. Am Heart J 1996;131:472-80.
24. Ishida S, Nakagawa M, Fujino T, et al. Circadian variation of QT interval dispersion. J Electrocardiol 1997;30:205-10.
25. Oldroyd KG, Rankin AC, Gray CE, et al. Failure to reproduce the in vitro cardiac electrophysiological effects of naloxone in humans. Br J Clin Pharmacol 1994;37:289-94.
26. Liebelt EL, Ulrich A, Francis PD, et al. Serial electrocardiogram changes in acute tricyclic anti-depressant overdoses. Crit Care Med 1997;25: 1721-6.
27. Benhorin J, Merri M, Alberti M, et al. Long QT syndrome. New electrocardiographic characteristics. Circulation 1990;82:521-7.
28. Merri M, Benhorin J, Alberti M, Locati E, Moss AJ. Electrocardiographic quantitation of ventricular repolarization. Circulation 1989;80:1301-8.
29. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993;88:782-4.
30. Koch HJ, Raschka C. Capacitor-like theoretical heart model of the R-concordant T-wave on the base of repolarization inhomogenitics. Herz/Kreisl 1998;6:212-15.
31. Ackerman MJ, Clapham DE. Ion channels basic science and clinical disease. N Engl J Med 1997; 336:1575-86.
32. Day CP, James OFW, Butler TJ, Campbell KWF. QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet 1993; 341:1423-8.
33. Splawski I, Timothy KW, Vincent GM, et al. Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med 1997;336: 1562-7.